Collating Considerations in the Development & Manufacturing of Long-Acting Injectables (LAIs)
Time: 9:45 am
day: Day One
Details:
- Resolving formulation feasibility and delivery device selection issues toward product development
- Establishing in vitro-in vivo relationship (IVIVR) for quality control of LAI dosage forms
- Demonstrating bioequivalence of LAIs
- Reflecting on market development challenges for long-acting injectable drug products